Tissue transglutaminase: a new target to reverse cancer drug resistance

Por Budillon, Alfredo, Carbone, Carmine, Di Gennaro, Elena
Publicado em 2011

Synergistic antitumor interaction between valproic acid and capecitabine in breast cancer

Por Terranova-Barberio, Manuela, Gennaro, Elena DI, Roca, Maria Serena, Budillon, Alfredo
Publicado no J Immunother Cancer (2015)

Anti-VEGF Treatment Resistant Pancreatic Cancers Secrete Proinflammatory Factors that Contribute to Malignant Progression by Inducing an EMT cell phenotype

Por Carbone, Carmine, Moccia, Tania, Zhu, Cihui, Paradiso, Genni, Budillon, Alfredo, Chiao, Paul J., Abbruzzese, James L., Melisi, Davide
Publicado em 2011

Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1

Por Melisi, Davide, Xia, Qianghua, Paradiso, Genni, Ling, Jianhua, Moccia, Tania, Carbone, Carmine, Budillon, Alfredo, Abbruzzese, James L., Chiao, Paul J.
Publicado em 2011

Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype

Por Milone, Maria Rita, Pucci, Biagio, Bifulco, Katia, Iannelli, Federica, Lombardi, Rita, Chiara, Ciardiello, Bruzzese, Francesca, Carriero, Maria Vincenza, Budillon, Alfredo
Publicado no Oncotarget (2014)

Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles

Por Russo, Annapina, Maiolino, Sara, Pagliara, Valentina, Ungaro, Francesca, Tatangelo, Fabiana, Leone, Alessandra, Scalia, Giulia, Budillon, Alfredo, Quaglia, Fabiana, Russo, Giulia
Publicado no Oncotarget (2016)

Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid

Por Bizzarro, Valentina, Belvedere, Raffaella, Milone, Maria Rita, Pucci, Biagio, Lombardi, Rita, Bruzzese, Francesca, Popolo, Ada, Parente, Luca, Budillon, Alfredo, Petrella, Antonello
Publicado no Oncotarget (2015)

Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression

Por Terranova-Barberio, Manuela, Roca, Maria Serena, Zotti, Andrea Ilaria, Leone, Alessandra, Bruzzese, Francesca, Vitagliano, Carlo, Scogliamiglio, Giosuè, Russo, Domenico, D'Angelo, Giovanni, Franco, Renato, Budillon, Alfredo, Di Gennaro, Elena
Publicado no Oncotarget (2015)

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression

Por Ciardiello, Chiara, Roca, Maria Serena, Noto, Alessia, Bruzzese, Francesca, Moccia, Tania, Vitagliano, Carlo, Gennaro, Elena Di, Ciliberto, Gennaro, Roscilli, Giuseppe, Aurisicchio, Luigi, Marra, Emanuele, Mancini, Rita, Budillon, Alfredo, Leone, Alessandra
Publicado no Oncotarget (2016)

Sequential PET/CT with [(18)F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Canc...

Por Pecori, Biagio, Lastoria, Secondo, Caracò, Corradina, Celentani, Marco, Tatangelo, Fabiana, Avallone, Antonio, Rega, Daniela, De Palma, Giampaolo, Mormile, Maria, Budillon, Alfredo, Muto, Paolo, Bianco, Francesco, Aloj, Luigi, Petrillo, Antonella, Delrio, Paolo
Publicado no PLoS One (2017)

Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: results of the branch trial

Por Avallone, Antonio, Pecori, Biagio, Bianco, Franco, Aloj, Luigi, Tatangelo, Fabiana, Romano, Carmela, Granata, Vincenza, Marone, Pietro, Leone, Alessandra, Botti, Gerardo, Petrillo, Antonella, Caracò, Corradina, Iaffaioli, Vincenzo R., Muto, Paolo, Romano, Giovanni, Comella, Pasquale, Budillon, Alfredo, Delrio, Paolo
Publicado no Oncotarget (2015)

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short Radi...

Por Avallone, Antonio, Piccirillo, Maria Carmela, Delrio, Paolo, Pecori, Biagio, Di Gennaro, Elena, Aloj, Luigi, Tatangelo, Fabiana, D’Angelo, Valentina, Granata, Cinzia, Cavalcanti, Ernesta, Maurea, Nicola, Maiolino, Piera, Bianco, Franco, Montano, Massimo, Silvestro, Lucrezia, Terranova Barberio, Manuela, Roca, Maria Serena, Di Maio, Massimo, Marone, Pietro, Botti, Gerardo, Petrillo, Antonella, Daniele, Gennaro, Lastoria, Secondo, Iaffaioli, Vincenzo R, Romano, Giovanni, Caracò, Corradina, Muto, Paolo, Gallo, Ciro, Perrone, Francesco, Budillon, Alfredo
Publicado no BMC Cancer (2014)

Monitoring clonal evolution and resistance to EGFR blockade in the blood of metastatic colorectal cancer patients

Por Siravegna, Giulia, Mussolin, Benedetta, Buscarino, Michela, Corti, Giorgio, Cassingena, Andrea, Crisafulli, Giovanni, Ponzetti, Agostino, Cremolini, Chiara, Amatu, Alessio, Lauricella, Calogero, Lamba, Simona, Hobor, Sebastijan, Avallone, Antonio, Valtorta, Emanuele, Rospo, Giuseppe, Medico, Enzo, Motta, Valentina, Antoniotti, Carlotta, Tatangelo, Fabiana, Bellosillo, Beatriz, Veronese, Silvio, Budillon, Alfredo, Montagut, Clara, Racca, Patrizia, Marsoni, Silvia, Falcone, Alfredo, Corcoran, Ryan B., Di Nicolantonio, Federica, Loupakis, Fotios, Siena, Salvatore, Sartore-Bianchi, Andrea, Bardelli, Alberto
Publicado no Nat Med (2015)

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

Por Caponigro, Francesco, Di Gennaro, Elena, Ionna, Franco, Longo, Francesco, Aversa, Corrado, Pavone, Ettore, Maglione, Maria Grazia, Di Marzo, Massimiliano, Muto, Paolo, Cavalcanti, Ernesta, Petrillo, Antonella, Sandomenico, Fabio, Maiolino, Piera, D’Aniello, Roberta, Botti, Gerardo, De Cecio, Rossella, Losito, Nunzia Simona, Scala, Stefania, Trotta, Annamaria, Zotti, Andrea Ilaria, Bruzzese, Francesca, Daponte, Antonio, Calogero, Ester, Montano, Massimo, Pontone, Monica, De Feo, Gianfranco, Perri, Francesco, Budillon, Alfredo
Publicado no BMC Cancer (2016)

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimizat...

Por Avallone, Antonio, Piccirillo, Maria Carmela, Aloj, Luigi, Nasti, Guglielmo, Delrio, Paolo, Izzo, Francesco, Di Gennaro, Elena, Tatangelo, Fabiana, Granata, Vincenza, Cavalcanti, Ernesta, Maiolino, Piera, Bianco, Francesco, Aprea, Pasquale, De Bellis, Mario, Pecori, Biagio, Rosati, Gerardo, Carlomagno, Chiara, Bertolini, Alessandro, Gallo, Ciro, Romano, Carmela, Leone, Alessandra, Caracò, Corradina, de Lutio di Castelguidone, Elisabetta, Daniele, Gennaro, Catalano, Orlando, Botti, Gerardo, Petrillo, Antonella, Romano, Giovanni M., Iaffaioli, Vincenzo R., Lastoria, Secondo, Perrone, Francesco, Budillon, Alfredo
Publicado no BMC Cancer (2016)

New Prognostic and Predictive Markers in Cancer Progression

Publicado em 2021